Cancer stem cells (CSCs) are often characterized by high expression of the anti-inflammatory gene NRF2 and by shaping a TME rich in TGF-β, thereby promoting chemotherapy resistance, metastasis, and recurrence. Here, TGFB1 is linked to cancer.